In the media

<p>Francesc Posas, director at IRB Barcelona</p>
22 Oct 2018 - PharmaBoardroom

The magazine Pharma Board Room has published an interview with Francesc Posas, director of IRB Barcelona, in which he explains the role of the institute as a bridge between basic research and specific treatments for patients: "IRB Barcelona is well positioned. Our exceptional faculty is producing some excellent science that will undoubtedly improve people's quality of life," said Posas.

Link to Pharma Board Room

<p>Francesc Posas, director at IRB Barcelona</p>
15 Oct 2018 - TV3

TV3 has reported on the campaign "Legado Solidario", an initiative involving 25 organisations, among them IRB Barcelona. In the report, Francesc Posas, director of the institute, talks about the bequest of 1.5 € million the centre received last year to support cancer research and metastasis.

Link to TV3

<p>Source: TV3</p>
10 Oct 2018 - TV3 & OTHER MEDIA

La Razón, TV3, La Sexta, Men's Health and New Atlas, among other local and international media, have published an article about the study done at IRB Barcelona and Vrije Universiteiti Brussel. The study has identified camelid nanobodies able to block EGF, a protein that is abundant in tumour cells and that helps them to proliferate.

Link to TV3

Link to ...

<p>Angel R. Nebreda, head of the Signalling and Cell Cycle Laboratory at IRB Barcelona</p>
7 Oct 2018 - La Opinión de Zamora

The newspaper "La Opinion" interviewed Angel R. Nebreda, ICREA researcher at IRB Barcelona, who will be participating in a conference on breast cancer on October 18 within the Health Forums of La Opinion and El Correo de Zamora. In this conference, he will be talking about his work in the lab on tumour formation and his efforts to unravel the mechanisms responsible for the transformation of normal tissue to a tumour.

Link to La Opinión

<p>Manuel Serrano leads the Cellular Plasticity and Disease group at IRB Barcelona</p>
5 Oct 2018 - Futuro a fondo

“Futuro a fondo” has published an article about the video "Meet Our Scientists", starring Manuel Serrano, a researcher at IRB Barcelona. In the video he talks about his research into how damaged tissues are repaired and therapies based on regenerative medicine.

Link to Futuro a fondo

<p>Drosophila epithelium subjected to chromosomal instability (CIN): cells start invading the neighbouring tissues. Magenta labels the nuclei of all the epithelium while green labels the membranes of cells subjected to CIN (L Barrio, IRB Barcelona)</p>

La Vanguardia, Biotech, Salud y Medicina, among other media, have published an article on the study led by IRB Barcelona researcher Marco Milán. The study shows that chromosomal instability itself can induce invasive behaviour in epithelial cells, and identifies the underlying molecular mechanisms involved.

Link to La Vanguardia

Link to Biotech...

<p>Joan Massagué. Source: SINC</p>
30 Sep 2018 - Agencia SINC

SINC has published an interview with Joan Massagué, president of the Scientific Committee at IRB Barcelona and director of the Sloan Kettering Institute in New York, in which he comments on metastasis: "Most are annihilated by the immune system, but others mock the defenses, they manage to nest and over time they can grow. That's the metastasis: it's an exception, something that did not have to happen. Metastasis is like a criminal. That in a society there is delinquency does not mean that all people are delinquents ".

Link to Agencia SINC

26 Sep 2018 - La Vanguardia

La Vanguardia reports on a recent study published by Marco Milán’s lab in the journal Developmental Cell. On the basis of their findings in the fruit fly (Drosophila melanogaster), the scientists have concluded that the chromosomal instability characteristic of tumours can promote invasive behaviour in cancer.

Link to La Vanguardia: Demuestran que la inestabilidad cromosómica de tumores promueve la metástasis (in Spanish)

25 Sep 2018 - Pú

The digital newspaper Público and other media have echoed a study headed by the Universitat Autònoma de Barcelona (UAB) and involving researchers from the Chemistry and Molecular Pharmacology Programme at IRB Barcelona that offers a promising advance towards a treatment for Parkinson’s disease,.

Published in the journal PNAS, the study has revealed that a small molecule, called SynuClean-D, disrupts the formation of amyloid fibers of alpha-synuclein—the process that triggers the development of Parkinson’s disease—and reverses the neurodegeneration that ensues.

Jesús Garcia, Salvador Guardiola, Ernest Giralt and Xavier Salvatella are among...

24 Sep 2018 - Ara

Almost one in every four people living in Barcelona was born abroad. They have come to the city to study, to work, for love, and to seek refuge. The newspaper ARA has interviewed some of these people to find out what they think of the city, among them Camille Stephan-Otto Attolini, head of the Biostatistics and Bioinformatics Facility at IRB Barcelona.

Link to ARA newspaper: Com veuen la ciutat barcelonis arribats d'arreu